PANAGORA ASSET MANAGEMENT INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 883677
Boston, MA
Position in ARWR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,861,245
-$26,055,556 QoQ
Shares Held
35,103
-92.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#167
of 497 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. ARWR ranks #32 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in ARWR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,861,245 | 35,103 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $28,916,801 | 461,193 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,387,052 | 35,955 | Shares | Sole | 2026-02-13 | |
| 2024-03-31 | $530,301 | 18,542 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,609,017 | 85,262 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,564,588 | 207,093 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $9,044,160 | 253,622 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,364,757 | 250,581 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,977,800 | 246,001 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,257,383 | 219,588 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $563,183 | 15,995 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $735,610 | 15,995 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,060,468 | 15,995 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $998,567 | 15,995 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,474,775 | 17,807 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,441,380 | 21,737 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,667,880 | 21,737 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $935,995 | 21,737 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,715,074 | 86,017 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,594,326 | 194,450 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||